Virtus LifeSci Biotech Clinical Trials ETF
9 hedge funds and large institutions have $940K invested in Virtus LifeSci Biotech Clinical Trials ETF in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
86% less call options, than puts
Call options by funds: $17K | Put options by funds: $123K
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
9
Holding in Top 10
–
Calls
$17K
Puts
$123K
Top Sellers
| 1 | -$1.05M | |
| 2 | -$53.5K | |
| 3 | -$19.7K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.02K |
